Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Tropical threat looms: Gulf Coast braces for potential storm development As the Gulf Coast continues to recover from the recent devastation of Hurricane Helene, a new tropical threat… byPallavi MadhirajuOctober 1, 2024